The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pathologic complete response rates observed in women with locally advanced and inflammatory breast cancer receiving neoadjuvant carboplatin and paclitaxel.
Arvind Manohar Shinde
No relevant relationships to disclose
John H Yim
No relevant relationships to disclose
Laura Kruper
No relevant relationships to disclose
Courtney Vito
No relevant relationships to disclose
Steven L. Chen
No relevant relationships to disclose
Isaac Benjamin Paz
No relevant relationships to disclose
Thehang H. Luu
No relevant relationships to disclose
Tomoko Tagawa
No relevant relationships to disclose
Kim Wai Yu
No relevant relationships to disclose
Sharon Wilczynski
No relevant relationships to disclose
Sally Shaw
No relevant relationships to disclose
Lalit Vora
No relevant relationships to disclose
Jinha Mark Park
No relevant relationships to disclose
George Somlo
Consultant or Advisory Role - Celgene
Research Funding - Celgene